Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) Free Cash Flow (FCF): $5.26B

The free cash flow (FCF) for Danaher Corporation (DHR) is $5.26B. It is below its 12-month average by 0.34% ($5.28B).

DHR Free Cash Flow (FCF) Chart

DHR Free Cash Flow (FCF)
$5.26B-0.68% 1Y
Zoom

DHR Average Free Cash Flow (FCF) Chart

DHR Current vs Average Free Cash Flow (FCF) Chart

DHR Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$5.26B

FREE CASH FLOW (FCF) AVG TTM

$5.28B

FREE CASH FLOW (FCF) AVG 3Y

$5.93B

FREE CASH FLOW (FCF) AVG 5Y

$6.03B

FREE CASH FLOW (FCF) AVG 10Y

$4.73B

FREE CASH FLOW (FCF) AVG 15Y

$4.10B

FREE CASH FLOW (FCF) AVG 20Y

$3.47B

CURRENT VS TTM AVG

-0.34%

CURRENT VS 3Y AVG

-11.24%

CURRENT VS 5Y AVG

-12.78%

CURRENT VS 10Y AVG

+11.13%

CURRENT VS 15Y AVG

+28.44%

CURRENT VS 20Y AVG

+51.78%

FCF Analysis

Free Cash Flow (TTM)

$5.26B

FCF Yield

3.95%

Price/FCF

25.3

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Danaher Corporation Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Danaher Corporation (DHR)?
The free cash flow (FCF) for DHR stock is $5.26B.
What is the TTM average free cash flow (FCF) for Danaher Corporation (DHR)?
The TTM average free cash flow (FCF) for DHR stock is $5.28B.
What is the 3Y average free cash flow (FCF) for Danaher Corporation (DHR)?
The 3Y average free cash flow (FCF) for DHR stock is $5.93B.
What is the 5Y average free cash flow (FCF) for Danaher Corporation (DHR)?
The 5Y average free cash flow (FCF) for DHR stock is $6.03B.
What is the 10Y average free cash flow (FCF) for Danaher Corporation (DHR)?
The 10Y average free cash flow (FCF) for DHR stock is $4.73B.
What is the 15Y average free cash flow (FCF) for Danaher Corporation (DHR)?
The 15Y average free cash flow (FCF) for DHR stock is $4.10B.
What is the 20Y average free cash flow (FCF) for Danaher Corporation (DHR)?
The 20Y average free cash flow (FCF) for DHR stock is $3.47B.

Danaher Corporation Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2025-12-31$5.26B
2024-12-31$5.30B
2023-12-31$5.78B
2022-12-31$7.37B
2021-12-31$7.06B
2020-12-31$5.42B
2019-12-31$3.32B
2018-12-31$3.44B
2017-12-31$2.91B
2016-12-31$2.93B
2015-12-31$3.29B
2014-12-31$3.29B
2013-12-31$3.05B
2012-12-31$2.96B
2011-12-31$2.29B
2010-12-31$1.87B
2009-12-31$1.61B
2008-12-31$1.67B
2007-12-31$1.48B
2006-12-31$1.41B
2005-12-31$1.08B
2004-12-31$917.31M
2003-12-31$781.20M
2002-12-31$644.92M
2001-12-31$527.89M
2000-12-31$423.74M
1999-12-31$265.40M
1998-12-31$-284.70M
1997-12-31$215.60M
1996-12-31$165.80M

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair